Making tumor necrosis factor blockers safer: a prescriber's consumptive challenge.
Keane
Joseph
J
Ní Cheallaigh
Cliona
C
D018501:Antirheumatic Agents / Q000009:adverse effects*; D006801:Humans; D012216:Rheumatic Diseases / Q000188:drug therapy / Q000276:immunology; D014376:Tuberculosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha